A dedicated focus on improving women’s health
Syneos Health is very active in supporting biopharmaceutical companies developing innovative solutions in women’s health. Our expertise encompasses:
- Successful design, implementation and execution of 86 women’s health clinical trials since 2013, treating 46,800 patients at 5,240 sites globally
- 14 studies with a fertility focus since 2013, treating 7,726 patients at 373 sites globally
- A dedicated women’s health group within the General Medicine Business Unit (BU) comprised of more than 200 clinical, scientific and regulatory professionals, including five full-time in-house OB-GYN physicians, executives seasoned in running women’s health trials, accomplished project directors, project managers, and clinical research associates (CRAs)
Considering the diverse disciplines that intersect with women’s health studies, we frequently collaborate across our integrated network of clinical and commercial subject matter experts within Syneos Health to ensure we have considered your trial needs from every possible angle. For example, while recently conducting a tightly defined vaccine trial with pregnant women, we leveraged the extensive vaccine experience of our infectious disease colleagues to ensure the optimal protocol development for this highly targeted patient population. The unique ability to tap into Syneos Health expertise from across the clinical and commercial continuum allows you to receive the most holistic planning, management and oversight for your clinical trials at every stage.
There is never a “one size fits all” outsourcing plan for a clinical trial. This is especially true in the women’s health space. Our therapeutically aligned experts listen to your needs and work with you to customize the design from providing protocol considerations to helping define your risk-based monitoring strategy. We will remain nimble and flexible in order to deliver your study with the maximum efficiency while maintaining data integrity.